文献速递瓣膜外科主动脉外科

升主动脉严重钙化患者中的经导管主动脉瓣置入

Transcatheter aortic valve insertion in patients with hostile ascending aorta calcification.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-04-07

回顾性分析665例经导管主动脉瓣置入患者,其中36例(5%)因升主动脉严重钙化被定义为困难升主动脉组,629例为对照组。困难升主动脉组手术死亡2例(6%),对照组18例(3%),P=0.296;困难升主动脉组无卒中,对照组15例(2%),P=1.00;3年死亡率两组无差异(48.5%±9.0% vs 35.9%±2.3%,P=0.484)。作者认为该人群手术相关并发症和死亡率低,数据支持经股动脉优先策略。

要点

  • 困难升主动脉钙化患者经导管主动脉瓣置入手术死亡6%,对照组3%,无统计学差异。
  • 困难升主动脉组无卒中发生,对照组卒中发生率2%。
  • 3年死亡率困难升主动脉组48.5%±9.0%,对照组35.9%±2.3%,无统计学差异。

核心结论

  • 经导管主动脉瓣置入在升主动脉严重钙化患者中可低手术相关并发症和死亡率完成,数据支持经股动脉优先策略。

研究设计与样本

  • 回顾性综述2008年11月至2015年12月连续665例经导管主动脉瓣置入患者记录。
  • 困难升主动脉定义为术前CT显示显著主动脉钙化且外科医生认为无法安全阻断主动脉,共36例(5%);对照组629例(95%)。

主要发现

  • 手术死亡:困难升主动脉组2例(6%),对照组18例(3%),P=0.296。
  • 卒中:困难升主动脉组0例,对照组15例(2%),P=1.00。
  • 3年死亡率:困难升主动脉组48.5%±9.0%,对照组35.9%±2.3%,P=0.484。
  • 替代入路与死亡率增加相关(HR 1.41,95%CI 1.09-1.82,P=0.009)。

临床怎么用

  • 作者认为经导管主动脉瓣置入可用于升主动脉严重钙化患者,数据支持经股动脉优先策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Calcification of the ascending aorta complicates aortic valve replacement. Transcatheter aortic valve replacement is an alternative procedure in this situation, but it requires manipulation through the hostile area in the ascending aorta. We reviewed our transcatheter aortic valve insertion experience to better understand the surgical mortality risk of valve insertion in patients with extensive calcification of the ascending aorta. METHODS: We retrospectively reviewed the records of 665 consecutive patients who received transcatheter aortic valve insertion from November 2008 through December 2015. We defined a hostile ascending aorta on the basis of preoperative computed tomography scan documenting significant aortic calcification that the surgeon believed precluded safe aortic cross-clamp application. There were 36 patients (5%) who met our definition of a hostile ascending aorta (hostile aorta group) and 629 (95%) who did not (control group). RESULTS: Surgical mortality occurred in 2 patients (6%) in the hostile aorta group and in 18 (3%) in the control group (P = .296). There were no strokes in the hostile aorta group, whereas there were 15 (2%) in the control group (P = 1.00). There was no difference in mortality at 3 years for patients in the hostile aorta (48.5% ± 9.0%) and control groups (35.9% ± 2.3%; P = .484). Alternative access was associated with an increased risk of mortality (hazard ratio, 1.41; 95% confidence interval, 1.09-1.82; P = .009). CONCLUSIONS: Transcatheter aortic valve insertion can be performed with low procedure-related morbidity and mortality in patients with hostile calcification of the ascending aorta. Our data support a transfemoral-first paradigm in this patient population.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nakasu A, Greason KL, Nkomo VT, et al. Transcatheter aortic valve insertion in patients with hostile ascending aorta calcification. J Thorac Cardiovasc Surg. 2018. PMID: 29773445. doi:10.1016/j.jtcvs.2018.03.125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。